These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii. Cui JC, Liu YN, Chen LA. J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030 [No Abstract] [Full Text] [Related]
10. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii? Grandesso S, Sapino B, Amici G, Mazzucato S, Solinas M, Gion M. New Microbiol; 2014 Oct; 37(4):503-8. PubMed ID: 25387287 [Abstract] [Full Text] [Related]
16. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii. Wang P, Bowler SL, Kantz SF, Mettus RT, Guo Y, McElheny CL, Doi Y. J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901 [Abstract] [Full Text] [Related]
17. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii. Garza-González E, Llaca-Díaz JM, Bosques-Padilla FJ, González GM. Chemotherapy; 2010 Dec; 56(4):275-9. PubMed ID: 20693798 [Abstract] [Full Text] [Related]
18. Isolation of uncommon respiratory and enteric Acinetobacter baumannii from hematologic patients and emergence of tigecycline-resistance. Savini V, Catavitello C, Pompetti F, Talia M, Costanzi L, Balbinot A, Febbo F, Di Zacomo S, Esattore F, D'Antonio D. J Infect; 2008 Dec; 57(6):497-500. PubMed ID: 19027170 [No Abstract] [Full Text] [Related]
19. In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. Insa R, Cercenado E, Goyanes MJ, Morente A, Bouza E. J Antimicrob Chemother; 2007 Mar; 59(3):583-5. PubMed ID: 17213264 [No Abstract] [Full Text] [Related]